
|Articles|October 27, 2020
- Vol 65 No 10
- Volume 65
- Issue 10
What did you think of this month’s cover story? October 2020
Let us know: Send us a message on Facebook, Twitter, or send an email to our editorial staff.
Advertisement
In the second installment of a 2-part Infertility series, ‘
Read Part 1 here:
Let us know: Send us a message on
Articles in this issue
about 6 years ago
Mental health support is critical during pandemicabout 6 years ago
Was this a failure to diagnose ovarian failure?about 6 years ago
Stand firm with scienceabout 6 years ago
Vulvar infection in patient with acute myeloid leukemiaabout 6 years ago
Choosing the right pillabout 6 years ago
Treatment of the infertile coupleabout 6 years ago
An imaging approach to early pregnancy failureabout 6 years ago
Age of anxietyabout 6 years ago
Test your knowledge of this rare vulvar conditionAdvertisement
Related to this article

Lisa Taylor-Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.

Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.

A recap of the top video interviews from Contemporary OB/GYN's coverage of The Menopause Society 2026 Annual Meeting in San Diego.

Susan Reed, MD, MPH, MS, and Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, weigh in on FDA boxed warning removals for menopausal hormone therapy.

The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.

A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.

Chrisandra Shufelt, MD, on using a cardiovascular risk score to guide hormone therapy candidacy at menopause.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Choosing Among Hormonal and Nonhormonal VMS Therapies in Menopause
2
FDA removes boxed warnings from 3 more menopausal hormone therapy products
3
Top video interviews from The Menopause Society 2026 Annual Meeting
4
Top headlines in women's health from October 2026
5

